Cite

HARVARD Citation

    Chawki, S. et al. (2021). Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY). Open forum infectious diseases. p. . [Online]. 
  
Back to record